Recent Quotes

My Watchlist

Indicators

AdvisorShares Trust AdvisorShares Pure US Cannabis ETF (NY: MSOS )

3.710 +0.110 (+3.06%)

Official Closing Price Updated: 8:00 PM EST, Dec 20, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	5,128,512
Open	3.670
Bid (Size)	3.710 (16)
Ask (Size)	3.730 (12)
Prev. Close	3.600
Today's Range	3.610 - 3.850
52wk Range	3.420 - 11.37
Shares Outstanding	1,305,750
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?

December 04, 2024

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

Via Benzinga

Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee

November 21, 2024

The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.

Via Benzinga

Performance

YTD	-45.12%	-45.12%
1 Month	-18.82%	-18.82%
3 Month	-47.15%	-47.15%
6 Month	-52.25%	-52.25%
1 Year	-43.01%	-43.01%

More News

Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General

November 13, 2024

Via Benzinga

Matt Gaetz Is Trump's Attorney General Pick: Would-Be Top Cop Is Under House Ethics Investigation

November 13, 2024

Via Benzinga

Turnaroud Tuesday: Did Canna Finally Bottom?

November 12, 2024

Via Talk Markets

Stocks Of The Day: 4-Pillar Power Plays You Can’t Miss - Today’s Biggest Movers

November 13, 2024

Via Talk Markets

Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis

November 12, 2024

Via Benzinga

The Good, The Bad, And The Ugly: A Recap Of Post-Vote Winners & Losers

November 10, 2024

Via Talk Markets

Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?

November 07, 2024

Via Benzinga

Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close

November 06, 2024

Via Benzinga

Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty

November 06, 2024

Via Benzinga

Cannabis Reform Stumbles In 2024 Elections: A State-By-State Breakdown As Stocks Take A Hit

November 06, 2024

Via Benzinga

Marijuana Capital Markets: Bright 2025 Outlook Amid Regulatory Shifts

November 04, 2024

Via Benzinga

Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters

October 31, 2024

Via Benzinga

AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest

October 23, 2024

Via Benzinga

'The Biggest Opportunities For Investors Outside AI': Optimism Reigns At Benzinga Conference Amid Talks Of Cannabis Rescheduling, Tech Advances

October 11, 2024

Via Benzinga

EXCLUSIVE: Weed Companies Will Be Treated Like Normal Businesses Once This Tax Provision Goes Away, Experts Say

October 08, 2024

Via Benzinga

Profit from the Green Wave: Top Cannabis Stocks to Watch

October 02, 2024

Via MarketBeat

Cannabis Investor Sentiment Softens As Institutional Confidence Wanes, Survey Shows

September 13, 2024

Via Benzinga

Will The DEA Complete Cannabis Rescheduling? Hear From Experts The Day After Harris-Trump Debate

September 10, 2024

Via Benzinga

Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains

September 09, 2024

Via Benzinga

Looking for the Next Big Growth Opportunity? It Might Not Be in Artificial Intelligence.

September 07, 2024

Via The Motley Fool

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

September 05, 2024

Via Benzinga

Cheaper Than A Big Mac: Weed Penny Stocks Emerge As Winners Amidst Market Downturn

August 29, 2024

Via Benzinga

Congressman Blumenauer Slams DEA For Postponing Marijuana Rescheduling, Places Hope In Soon-To-Be President Harris

August 28, 2024

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.